Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NES/E2 Transdermal Gel for Ovulation Suppression
NCT00796133Phase 2Completed
- Sponsor
- Population Council
- Start
- Nov 2008
- Primary completion
- Jan 2014
- Modality
- Orthosteric Ligands
- Countries
- 3
01
Overview
Phase 2, randomised, open-label trial of segesterone and estradiol topical in pregnancy, sponsored by Population Council. Primary endpoint: Ovulation suppression based on Progesterone levels at 8 months. Started Nov 2008; status: completed.
02
Drugs
segesteroneestradiol topical
03
Conditions
pregnancy
Beyond the preview
Go deeper on NCT00796133.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00796133.